Member Info for Balanced66

Some good consolidation after the recent rise. Look forward to the next news for Chronocort. That's not long to wait now either on the expected q1 2021 approval.

We have an SPA meeting with FDA due as well so there should be news on that as well.

All looking good and professionally run. No worries like other biotechs - funding, phase 2, phase 3 approvals and so on.

I think Dana was here to achieve change and he has helped in doing that.

I believe the real benefits of the change are to come and business performance will be the catalyst for real sustained share price increase. Those that wanted to get out had their chance with the short spike in our share price.

I always think there are only limited opportunities for investing in good companies and I think fundamentally we are good with the right management in place.

People who sold here will have had to go and find a new home for their money and that's easier said than done. As the famous investors will tell you they made most of their money from only a handful of investments. There aren't that many good businesses out there. Buffet made most of his Berkshire Hathaway money from Coca Cola in the early days.

I would like there to be more due diligence in our company so that we are picking more winners. But like I say you only need one share to take off and it will make up for deficiencies elsewhere. We should be thankful for our ggp holding but we can't just sit back and rely on that completely we need to find more ggp type holdings. If we want to move forward and become a 20 million pound plus company then we need to do that - selection of successful new investments as well as growth in existing investments will achieve this

Engage could be one of those and so could one or two of our other holdings.

If Truspine takes off and is succesful it could return 5-10 fold within the next 5 years. So on that basis our investment at the moment is sufficient. There are risks to biotech type investments (I have a few and so am familiar with some of the issues here) so it's always good to invest any further sums with those type of investments when progress is being made and not before.

Just my thoughts and ideas others will have their own.

Gla.

Yes happy to hold at the moment. When people talk about sky high valuations we cannot be accused of that.

Value normally aligns with the share price over time so I wouldn't expect such a big gap to remain between nav and share price in future. It's a share that would fit in with Benjamin Graham' s value philosophy so there is a margin of safety here. A good spread of investment type holdings is good for pf management. Too many shares on Aim are speculative in nature with no real prospects or assets to back them up.

You have to give credit to the management where due. When ggp doubled and quadrupled etc. most investors would have probably sold half or some on doubling. Management here didn't do that - risky but being a geologist AC knew the terrain and predicted, rightly a higher price. Because of this today after the 2 sales we still have a holding worth £4 million.

I'm not an expert on ggp but if the proven gold is higher than expected then the share price could be back in the high 20s or ascend to 30s by later this year.

That would be a good time for further sales.

The sale of GGP would have been done it seems some weeks before the spike in the price so they have not achieved the higher prices from the sale. If they needed to realise the money beforehand to take part in the Zuuse placing then they can't be criticised for the low ggp price achieved.

However they need to start getting some top prices in future sales now from the sale of the biggest asset.

Just a shame with the timing just one of those things imo.

Think they could also buy individual products and then use their now improved and bigger distribution networks to extract maximum value from them.

I don't know anything about VAL Bojo and I'm not saying it's a bad company. I was just talking in general terms. A lot of people have probably got burnt so will be more cautious on other investments. That's not necessarily a bad thing as too much speculation is not good for any of us as it can spread and cause problems for other investors.

I still remain positive here let's hope we get good news.

There may not be enough shares available to buy in the market. I would wait for progress at Truspine first. They have the FDA submission to make yet and that may or may not get approved and there could be delays in the submission and/or approval from fda. On approval obviously the price will go up but the prospects would have also improved. There will be further funding rounds yet when we will have chance to subscribe if it is in out interests to do so.

Otherwise our pf will become too heavy in very early stage companies which Truspine still is - even after FDA approval sales will take some time to build up and then presumably they will have to apply for further FDA approvals on their other products.

I'm not too keen on us investing too heavily in these early stage companies unless we are getting the shares at a big discount. We didn't get any discount it seems on Truspine. We have done better in the prices obtained on the other companies such as Engage and Fresho.

Yes strange days. Maybe it's the Val effect?

I always aim to be in quality businesses in case there is a downturn and then you're stuck with them. The quality businesses are more likely to pull through/survive over the long term.

During the dot com craze of the late 90's all sorts of rubbish increased as well as the good businesses and then investors were left holding them many of which went bust later.

I'm not sure if biotech valuations are over stretched here - I would say not but over the pond they probably are? They have always been high there though you have biotech companies valued in the billions there that would be worth maybe 200-300 million here. Strange that.

With Imm the management leaves a lot to be desired but I'm holding it on "value" principles and hoping the science pulls us through in spite of the management.

I didn't expect that with sng to be honest. It have a tiny holding free carried but I'm thinking I should have sold around 220 when I had the chance.

Think Scoredagainsteps is one of the few people who have made money on imm so far.

Biotechs have had a good run so far - everything has been lifted pretty much (except us).

There's new management coming now let's wait and hear from them now and hopefully our fortunes start improving.

Yes are others what are called lifestyle companies and we are the real deal.

Compare us to GDR's announcement this morning. Is that the first approval? Shocking!

They were only around 6 weeks or so behind us at the time in March when they announced their covid test.

How far we have advanced in sales and products, second and third generation and new products and gdr are still to make a sale!

Down to management in large part for the different fortunes.

Yes this company hasn't failed us. I expect a whole load of new products and sales in the next few months including a lateral flow test - I'm really confident that the company will be working on one. Why wouldn't they? They are a leading diagnostic company and have a.division already that makes these for other tests.

More deals and acquisitions later will improve fundamentals imo as time goes by.

Diagnostic companies don't need a lot of steady income for high 20-30 pe market caps. Just my views.

Some consolidation is a good thing to build a strong base before the next move up.

We were only £3 at the beginning of September so this is a good level before the next moves up. The move up to this level has been smooth as well so that is good.

We are undervalued but like someone said this morning nothing goes up in a straight line so patience is required imo.

We are making strong sales and the old year end revenue forecasts have already been smashed with the latest government deal. It's just that Nova aren't going to come out and say look at all this money we are making from this virus. They have too big a customer in the government s of the UK and France to do that.

Hey not even a £5 million Hungary order gets a mention. That's saying something.

Are we not led by the French market though so would a main market listing help?

It is disappointing but which one of these companies has actually met the deadlines at the moment?

You have even Aau (I'm invested and that is coming good now) where investors have been waiting since last year for the new investor to come on board. You have delays in other companies as well for permits/funding such as bmv, grl, Conroy gold, keras resources etc.

I'm quite new to the mining sector but these kind of delays are common. It's whether people think the deal will go through eventually or not.

80 million market cap when Alkindi worldwide sales alone will give it a p/e ratio of 20 (low for a growth biotech) for a market cap well in excess of several hundred million pounds. That's before anything else kicks in from the other drugs. Can see this being a long term core holding in my pf.

Our shareholding in Eton has also increased and worth a lot more than when we received it.

One of the very few companies on aim with an approved drug and further drugs to be approved shortly.

A future billion pound plus company in the making.

Just have the decency to admit defeat. You have failed in your mission from 39p.

Must be painful for you like getting hit by a 9 inch nail. Lol.

Here's a post from the man himself protecting people from the rampers at 39p. Can see why you call him 9inchfail. People like him will always be spectators while others make the money:

"9inchNail

Posted in: NCYT

Posts: 510

Price: 39.00

No Opinion

RE: There is room for more than one supplier31 Jan 2020 22:41
This share is now the UK's favourite ramp, thanks to coronavirus. Beware, it can go down as quickly as it rises. A testing kit, but today 2 Chinese tourists were tested in the UK as being infected. Is there a shortage of test kits, maybe if hundreds or thousands become ill. Who knows eh? Time to stay indoors and keep them hands washed."